brooklyn is focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases.  brooklyn’s most advanced program is irx-2, a human cell-derived cytokine therapy, s

Eterna Therapeutics Inc. Common Stock

Bought 25% more ERNA

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio